Jafron

Plasma TherapiesHA380Haemoperfusion CartridgeRequest a demoProduct InformationProduct DescriptionThe HA380 is a Haemoperfusion cartridge that can be used as a stand alone device or in conjunction with other other extra-corporeal therapies. The HA380 has the ability to remove pro-inflammatory cytokines in cytokine storm and other cellular inflammatory markers. Clinical Indications Include: Patients unresponsive to vasopressor support after fluid resuscitation Hyper-lactataemia not responding to standard of care COVID-19 rescue therapy (2 + 1 + 1 therapy) See publication 1 Patients unresponsive to standard of care who have multiple organ failure Patients exhibiting signs of Damage Associated Molecular Patterns (DAMPS) or Pathogen Associated Molecular Patterns (PAMPS) Intra-operative cardiac surgery where the patient already has significant pre-existing cellular inflammatory activation caused by  Heart Failure or where a VAD device has been implanted etc. Patients requiring long pump procedures such as Heart / Lung transplant and other procedures. Respiratory failure Conjunctive therapy with ECMO Request a free demonstrationCONTACTUsing the Jafron Adsorber in COVID-19 PatientsOrgan Crosstalk in Critical IllnessORDER CODESTECHNICALSNEWS & PUBLICATIONSFAQTUTORIALSORDER CODES HA380                      Product Description HA380 Haemoperfusion Cartridge 1 unit TECHNICALSTechnical Details: Product parameter   HA380   Loading capacity (ml)   380±3   Volume (ml)   150±5   Absorbent material   Styrene divinybenzene copolymers   Housing…

Plasma TherapiesHA330Haemoperfusion CartridgeRequest a DemoProduct InformationProduct DescriptionThe HA330 is a Haemoperfusion cartridge that can be used as a stand alone device or in conjunction with other other extra-corporeal therapies. The HA330 has the ability to remove pro-inflammatory cytokines and other cellular inflammatory markers found in “cytokine storm”. Clinical Indications Include: Patients unresponsive to vasopressor support Patients unresponsive to standard of care who have multiple organ failure Patients exhibiting signs of Damage Associated Molecular Patterns (DAMPS) or Pathogen Associated Molecular Patterns (PAMPS) Patients on ECMO Intra-operative cardiac surgery where the patient already has significant pre-existing cellular inflammatory activation such as Heart Failure where a LVAD device is to be implanted Patients requiring long pump procedures such as Heart / Lung transplant or other procedures. Request a free demonstrationCONTACTUsing the Jafron Adsorber in COVID-19 PatientsORDER CODESDETAILED FEATURESTECHNICAL INFORMATIONPUBLICATIONSORDER CODES HA330 Disposable Hemoperfusion Cartridge HA330 DETAILED FEATURESIndication Improves organ functions Clears excessive inflammatory mediators TECHNICAL INFORMATIONTechnical Details: Product parameter   HA330   Loading capacity (ml)   330±3   Volumn (ml)   185±5   Absorbent material   Styrene divinybenzene copolymers   Housing material   Polycarbonate   Sterilization method   Irradiation sterilization   Unit package   290mm(L)×105mm(W)×105mm(H) 0.90kg PUBLICATIONSCOVID-19: The use of Jafron Adsorber in…